Recombinant Human Interferon Market: Key Growth Drivers and Future Prospects
The Recombinant Human Interferon Market is expanding as demand for biologic therapies grows across viral infections, cancer, and other chronic conditions. The market was valued at USD 3.5 billion in 2024 and is projected to reach USD 6.5 billion by 2035, growing at a 5.6% CAGR during 2026–2035. Manufacturing advances are improving purification, production efficiency, and the availability...
0 Commentarios 0 Acciones 2 Views 0 Vista previa
Comunidad EDUCA https://comunidadeduca.com